Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis

Yoon Koo Kang, Shukui Qin, Keun Wook Lee, Sang Cheul Oh, In Ho Kim, Jong Gwang Kim, Yong Li, Zhuchen Yan, Jin Li, Li Yuan Bai, Catherine Chan, Akeem Yusuf, Anita Zahlten-Kümeli, Kate Taylor, Kensei Yamaguchi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology